Showing 1,241 - 1,260 results of 4,807 for search '"2008"', query time: 0.06s Refine Results
  1. 1241
  2. 1242

    Cholecystostomy as Bridge to Surgery and as Definitive Treatment or Acute Cholecystectomy in Patients with Acute Cholecystitis by Agnieszka Popowicz, Lars Lundell, Peter Gerber, Ulf Gustafsson, Emil Pieniowski, Helen Sinabulya, Krister Sjödahl, Andrianos Tsekrekos, Gabriel Sandblom

    Published 2016-01-01
    “…A review of medical records was performed on all patients residing in Stockholm County treated for AC in the years 2003 and 2008. Results. In 2003 and 2008 altogether 799 and 833 patients were admitted for AC. …”
    Get full text
    Article
  3. 1243
  4. 1244

    Treatment of Hepatitis C Post-Liver Transplantation Could Mitigate Discard Rates of Hepatitis C-Positive Deceased Donor Livers and Expand the Donor Pool by Jennifer Keller, Gary Marklin, Obi Okoye, Roshani Desai, Tej Sura, Ajay Jain, Chintalapati Varma, Mustafa Nazzal

    Published 2021-01-01
    “…This is a retrospective, observational study using Mid-America Transplant Services (MTS) database from 2008 to 2017. Comparison was made before the widespread use of DAAs 2008–2013 (pre-DAA) against their common practice use 2014–2017 (post-DAA). …”
    Get full text
    Article
  5. 1245

    Effect of individual health perception, health consultation, and other risk factors on undiagnosed hypertension in South Africa by Muchiri E. Wandai, Brian E. Dixon

    Published 2025-01-01
    “…The sample included 15,712 unique individuals (60.0% women) and 31,340 observations from the five survey waves (5,357 in 2008; 5,206 in 2010/11; 6,385 in 2012; 7,060 in 2014/15; and 7,332 in 2017). …”
    Get full text
    Article
  6. 1246
  7. 1247
  8. 1248

    Effects of removing reimbursement restrictions on targeted therapy accessibility for non-small cell lung cancer treatment in Taiwan: an interrupted time series study by Jason C Hsu, Chen-Fang Wei, Szu-Chun Yang

    Published 2019-03-01
    “…The prescribing rate of the targeted therapies increased by 15.58%, decreased by 10.98% and increased by 6.31% following the introduction of gefitinib as a second-line treatment in 2007, erlotinib as a second-line treatment in 2008 and gefitinib as as first line treatment in 2011, respectively. …”
    Get full text
    Article
  9. 1249

    The Critical Practitioner in Social Work and Health Care /

    Published 2008
    View in OPAC
    Book
  10. 1250

    A dictionary of finance and banking.

    Published 2008
    View in OPAC
    Book
  11. 1251

    Business Driven Information Systems / by Baltzan, Paige

    Published 2008
    Table of contents only
    View in OPAC
    Book
  12. 1252

    Poems and prose / by Rossetti, Christina Georgina, 1830-1894

    Published 2008
    Table of contents only
    View in OPAC
    Book
  13. 1253
  14. 1254
  15. 1255
  16. 1256
  17. 1257
  18. 1258
  19. 1259
  20. 1260